Key statistics
On Thursday, Arvinas Inc (ARVN:NSQ) closed at 25.11, 23.82% above the 52 week low of 20.28 set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 22.78 |
---|---|
High | 25.37 |
Low | 22.57 |
Bid | 24.33 |
Offer | 27.32 |
Previous close | 22.69 |
Average volume | 802.53k |
---|---|
Shares outstanding | 68.71m |
Free float | 62.73m |
P/E (TTM) | -- |
Market cap | 1.73bn USD |
EPS (TTM) | -4.79 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Arvinas to Participate in Upcoming Investor Conferences
- Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day
- Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
- Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
- Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
- Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
More ▼